Product Browser

Last updated: 2021/6/13

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

CD164 (Human) ELISA Kit 

  • Catalog # : KA5549
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • CD164 (Human) ELISA Kit is a sandwich enzyme-linked immunosorbent assay for quantitative detection of human CD164 in cell culture supernates, serum and plasma (heparin, EDTA, citrate).
  • Calibration Range:
  • 93.8 to 6000 pg/mL
  • Reactivity:
  • Human
  • Quality Control Testing:
  • Standard curve

    QC Testing of KA5549
    The standard curve is for the purpose of illustration only and should not be used to calculate unknowns. A standard curve should be generated each time the assay is performed.
  • Storage Instruction:
  • Store at 4°C for six months. For long term storage store at -20°C.
    Avoid repeated freezing and thawing.
  • Suitable Sample:
  • Cell culture supernates, serum and plasma (heparin, EDTA, citrate)
  • Sample Volume:
  • 100 uL
  • Label:
  • HRP-conjugated
  • Detection Method:
  • Colorimetric
  • Regulatory Status:
  • For research use only (RUO)
  • Applications
  • Quantification
  • Application Image
  • Quantification
  • Gene Information
  • Entrez GeneID:
  • 8763
  • Gene Name:
  • CD164
  • Gene Alias:
  • MGC-24,MUC-24,endolyn
  • Gene Description:
  • CD164 molecule, sialomucin
  • Gene Summary:
  • Sialomucins are a heterogeneous group of secreted or membrane-associated mucins that appear to play 2 key but opposing roles in vivo: first as cytoprotective or antiadhesive agents, and second as adhesion receptors. CD164 is a type I integral transmembrane sialomucin that functions as an adhesion receptor (Watt et al., 1998 [PubMed 9680353]; Forde et al., 2007 [PubMed 17077324]).[supplied by OMIM
  • Other Designations:
  • CD164 antigen, sialomucin
  • Gene Pathway
  • RSS
  • YouTube
  • Linkedin
  • Facebook